Edgar Jost

机构：Integrated Oncology (United States), Universitätsklinikum Aachen, RWTH Aachen University · ORCID：0000-0003-2998-2450

发表论文 267 篇 · 总被引 3708 次 · h-index 35

代表论文

Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial (2025 · Blood · 被引 11)
Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis (2025 · Leukemia · 被引 9)
Young unrelated donors confer a survival advantage for patients with myeloid malignancies compared to older siblings (2025 · Leukemia · 被引 7)
Daratumumab for PRCA after HCT: study and practical considerations from the EBMT Transplant Complications Working Party (2025 · Blood Cancer Journal · 被引 5)
ZIP10 as a potential therapeutic target in acute myeloid leukaemia (2025 · British Journal of Haematology · 被引 3)
Pretransplantation Hypomethylating Agents and Venetoclax in Acute Myeloid Leukemia Patients: A Real-World Analysis from the Cooperative Transplant Study Group (2025 · Transplantation and Cellular Therapy · 被引 2)